Able Laboratories, Inc. was a developer and
manufacturer of generic pharmaceutical products in tablet, capsule, liquid
and suppository dosage forms. In May 2005, Able suspended manufacturing and
distribution of its entire product line. The company currently is not generating
income or revenue, because of its suspension of manufacturing operations and
product recalls. The company has filed a petition to reorganize under
Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy
Court for the District of New Jersey, Trenton Division on July 18, 2005.